Results 71 to 80 of about 15,321 (234)

Disorder of Glucose Metabolism and Therapy: Implications on the Natural History of Advanced Chronic Liver Disease

open access: yesGE: Portuguese Journal of Gastroenterology
Introduction: Hepatogenous diabetes (HD) is a disorder of glucose metabolism (DGM) that develops as a complication of advanced chronic liver disease (ACLD) with an estimated prevalence of 20–70%.
Sofia Garcês Soares   +11 more
doaj   +1 more source

AMPK:a target for drugs and natural products with effects on both diabetes and cancer [PDF]

open access: yes, 2013
The AMP-activated protein kinase (AMPK) is a highly conserved sensor of cellular energy that appears to have arisen at an early stage during eukaryotic evolution.
Chen   +43 more
core   +3 more sources

Recent Developments in Diabetes Management: Exploring Receptors, Pathways, and Compounds

open access: yesBIO Integration
Diabetes mellitus (DM) is a widespread metabolic disorder with profound effects on vital organs. Often referred to as a “systemic” or “multi-organ” disorder due to the impact on key organs, such as the kidneys, pancreas, eyes, and heart, DM is ...
Pallavi Pandey   +3 more
doaj   +1 more source

Dietary Behaviors Among Patients with Type 2 Diabetes Mellitus in YOGYAKARTA, Indonesia [PDF]

open access: yes, 2011
Purpose: To describe dietary behaviors and examine relationships between selected factors and dietary behaviors among type 2 diabetes mellitus (T2DM) patients in Yogyakarta, Indonesia.Method: Seventy T2DM patients from a hospital in Yogyakarta who met ...
Kritpracha, C. (Charuwan)   +2 more
core   +2 more sources

Fenugreek : a natural prototype oral hypoglycaemic agent used in Malta [PDF]

open access: yes, 2009
Before the discovery of insulin therapy in 1921 and the development of effective oral hypoglycaemic therapy in 1926, pharmacological management of diabetes mellitus was restricted to empirical treatment often based on plant products and relegated to ...
Savona-Ventura, Charles
core  

Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization [PDF]

open access: yes, 2015
INTRODUCTION: Little research to date has examined antihyperglycemic agent (AHA) utilization among patients with type 2 diabetes mellitus (T2DM) around transitions of care from inpatient to outpatient settings. Discontinuity of care between inpatient and
Donna McMorrow   +2 more
core   +1 more source

Biguanides [PDF]

open access: yesDiabetologia, 1978
M, Nattrass, K G, Alberti
openaire   +2 more sources

Synergistic Interaction between Metformin and Sulfonylureas on Diclofenac-Induced Antinociception Measured Using the Formalin Test in Rats

open access: yesPain Research and Management, 2013
BACKGROUND: There is evidence that biguanides and sulfonylureas block diclofenac-induced antinociception (DIA) in rat models. However, little is known about the interaction between these hypoglycemics with respect to DIA.
Mario I Ortiz
doaj   +1 more source

Effects of Hyperglycemia and Iron Deficiency on Kidney and Heart Function in Type 2 Diabetes Disease

open access: yesBiomolecules & Biomedicine, 2006
Untreated anemia can caused significant cardiac and kidney damage. The aim of this study was to investigate the efficiency of anemia and hyperglycemia treatment in type 2 diabetes and their impact on kidney and heart impairment.
Belma Aščić-Buturović   +1 more
doaj   +1 more source

Patients With Type II Diabetes Mellitus At A Tertiary Care Hospital: A Prospective Study On Anti-Diabetic Drug Prescribing Patterns [PDF]

open access: yes
The main aim is to study on prescribing patterns of anti-diabetic drugs for patients with type- II diabetes mellitus. Out of 457 patients screened, 426patients were enrolled according to inclusion and exclusion criteria.
Dr. Sumera Iram   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy